# Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Study · id `cardio:ct-nct06911632` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06911632](<https://clinicaltrials.gov/study/NCT06911632>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06911632

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.

## Technical summary

Registry record NCT06911632. Randomized; no masking; primary purpose diagnostic. Start 2025-07-23 (actual); primary completion 2028-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 900 participants (planned count; ClinicalTrials.gov record NCT06911632, source copy `cardio:ctgov-nct06911632-2026-11-03`, retrieved 2026-11-18)
- Started: 2025-07-23 (actual) (ClinicalTrials.gov record NCT06911632, source copy `cardio:ctgov-nct06911632-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT06911632, source copy `cardio:ctgov-nct06911632-2026-11-03`, retrieved 2026-11-18)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT06911632, source copy `cardio:ctgov-nct06911632-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06911632, source copy `cardio:ctgov-nct06911632-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06911632-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Acronym: MOMENTOUS
- Condition: Pulmonary Hypertension
- Condition: Interstitial Lung Disease (ILD)
- Intervention (Device): ECG-based AI Device - Results Returned to Investigator
- Intervention (Procedure): Echocardiogram and Right Heart Catheterization
- Intervention (Device): ECG-based AI Device - Results Not Returned to Investigator
- Lead sponsor: Tempus AI
- Lead sponsor class: INDUSTRY
- Collaborator: United Therapeutics
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: Tempus AI (`cardio:org-tempus-ai`)
- Registry lists this organization as a collaborator: United Therapeutics (`cardio:org-united-therapeutics`)

## Provenance

Content hash: 86757f876e2926ce6476a429ade216957c0f8489e48b82b681c6b2ddd2d25e1f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
